Friday, 16 October 2026European Markets

KBC And TOTENS SPAREBANK Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(VIANEWS) - KBC (KBC.BR) is among this list of stock assets with the highest dividend rate and return on equity on the Financial Services sector.

Financial Asset Price Forward Dividend Yield Return on Equity
KBC (KBC.BR) €64.08 4.74% 13.02%
TOTENS SPAREBANK (TOTG.OL) kr206.00 4.59% 10.47%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. KBC (KBC.BR)

4.74% Forward Dividend Yield and 13.02% Return On Equity

KBC Group NV, together with its subsidiaries, provides integrated bank-insurance services primarily for retail, private banking, small and medium sized enterprises, and mid-cap clients. The company offers demand deposits and savings accounts; home and mortgage loans; consumer finance and SME funding services; credit, investment fund and asset management, and life and non-life insurance; and cash management, payments, trade finance, lease, money market, capital market products, and stockbroking services. It also provides digital and mobile banking services. The company was formerly known as KBC Bank and Insurance Holding Company NV and changed its name to KBC Group NV in March 2005. KBC Group NV was incorporated in 1935 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, KBC has a trailing twelve months EPS of €6.46.

PE Ratio

KBC has a trailing twelve months price to earnings ratio of 9.92. Meaning, the purchaser of the share is investing €9.92 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.02%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 4.74%.

Volume

Today's last reported volume for KBC is 582777 which is 21.41% below its average volume of 741628.

More news about KBC.

2. TOTENS SPAREBANK (TOTG.OL)

4.59% Forward Dividend Yield and 10.47% Return On Equity

Totens Sparebank provides various banking and financial products and services in Norway. The company offers savings and pension products; business and construction loans; leasing; overdrafts and bank guarantees; liability, business, data attack, property damage, craftsman, health, homeowners, collective, personnel, travel, occupational injury, agriculture, and vehicle insurance; and business and credit cards. It also provides online and mobile banking services; payment solutions; asset management; and real estate services. Totens Sparebank was founded in 1854 and is headquartered in Lena, Norway.

Earnings Per Share

As for profitability, TOTENS SPAREBANK has a trailing twelve months EPS of kr14.84.

PE Ratio

TOTENS SPAREBANK has a trailing twelve months price to earnings ratio of 13.89. Meaning, the purchaser of the share is investing kr13.89 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.47%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Apr 1, 2022, the estimated forward annual dividend rate is 10 and the estimated forward annual dividend yield is 4.59%.

More news about TOTENS SPAREBANK.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com